Literature DB >> 10403849

Hepatocyte nuclear factor 1 binds to and transactivates the human but not the rat CYP7A1 promoter.

J Chen1, A D Cooper, B Levy-Wilson.   

Abstract

Cholesterol 7alpha-hydroxylase (CYP7A1), a liver-specific enzyme, catalyzes the rate-limiting step in the degradation pathway of cholesterol to bile acids, and thus plays a key role in cholesterol homeostasis. To elucidate the mechanisms that control hepatic expression of the human CYP7A1 gene, we are studying the promoter region. Initially, we observed that up to 40% of the overall transcriptional activity of the promoter in HepG2 cells was associated with DNA sequences from -65 to -1 of the human gene. Within this region, a binding site for the liver-enriched transcription factor HNF-1 (-56 to -49) has been identified. Binding of HNF-1 to this site leads to transcriptional activation of the human promoter. The corresponding segment from the rat CYP7A1 gene does not bind HNF-1; instead, it is bound by the orphan receptors ARP-1 (COUP-TFII) and LXRalpha, that are implicated in dietary regulation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403849     DOI: 10.1006/bbrc.1999.0980

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A chronic high-cholesterol diet paradoxically suppresses hepatic CYP7A1 expression in FVB/NJ mice.

Authors:  Anne S Henkel; Kristy A Anderson; Amanda M Dewey; Mark H Kavesh; Richard M Green
Journal:  J Lipid Res       Date:  2010-11-20       Impact factor: 5.922

2.  The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene.

Authors:  D D Patel; B L Knight; A K Soutar; G F Gibbons; D P Wade
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

3.  Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter.

Authors:  Junko Sugatani; Kousuke Mizushima; Makoto Osabe; Kasumi Yamakawa; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori; Akira Ikari; Masao Miwa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

4.  The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.

Authors:  G Franck Gbaguidi; Luis B Agellon
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

Review 5.  Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?

Authors:  Kevin Mouzat; Cédric Raoul; Anne Polge; Jovana Kantar; William Camu; Serge Lumbroso
Journal:  Cell Mol Life Sci       Date:  2016-08-10       Impact factor: 9.261

6.  Two uniquely arranged thyroid hormone response elements in the far upstream 5' flanking region confer direct thyroid hormone regulation to the murine cholesterol 7alpha hydroxylase gene.

Authors:  Dong-Ju Shin; Michelina Plateroti; Jacques Samarut; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2006-08-09       Impact factor: 16.971

7.  Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice.

Authors:  Anne S Henkel; Brian LeCuyer; Shantel Olivares; Richard M Green
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-12-10

8.  Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice.

Authors:  Dany Gaillard; David Masson; Erwan Garo; Maamar Souidi; Jean-Paul Pais de Barros; Kristina Schoonjans; Jacques Grober; Philippe Besnard; Charles Thomas
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

9.  Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3.

Authors:  Mengdie Hu; Xiuting Huang; Xueyao Han; Linong Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-02       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.